Search PDMR transactions

Notifier
Name of person with notification obligation
Anette Lindqvist
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Anette Lindqvist
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Xbrane Biopharma AB
Issuer’s LEI code
5493008DKD05APTKQO39
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Xbrane Biopharma AB SE0007789409 Acquisition 1,500 Quantity 82.54 SEK 20/01/2021 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Xbrane Biopharma AB SE0007789409 Acquisition 20/01/2021 NASDAQ STOCKHOLM AB 1,500 (Quantity) 82.54 SEK
<< Back